Nicole A. Cipriani, MD, offers guidance for community oncologists regarding the role of BRAF p.V600E testing in patients with papillary thyroid carcinoma.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

A woman who was diagnosed with thyroid cancer at the age of 20 in 2022 was initially brushed off by doctors with her symptoms ...

Thyroid produces multiple essential hormones for vital life processes. Thyroid cancer has no symptoms and may be detected by ultrasound imaging incidentally for other medical conditions. An accurate ...

Rather than tumor size alone, the American Thyroid Association’s risk stratification system should be used when assessing papillary thyroid microcarcinomas, according to data published in ...

Papillary thyroid cancer is the most common type of thyroid cancer and usually grows slowly. It can remain undetected for a long time.

Stage 4 thyroid cancer is the most serious; stage 1 is the least severe. The stage of someone's cancer is determined by the size and spread of cancer cells from a tumor's primary site, in this case, ...

Conversion surgery after active surveillance for low-risk papillary thyroid carcinoma (PTC) led to no clinically meaningful differences in outcomes as compared with immediate surgery, according to ...

Papillary thyroid carcinoma is the most common type of thyroid cancer in children, accounting for about 90% of cases. It is also the leading cause of endocrine cancer in children, comprising 6% of all ...

Surgical management of advanced thyroid cancer is challenging and should evolve from multidisciplinary discussion integrating individual disease characteristics, expected surgical morbidity, and ...

Discover the impact of pregnancy on papillary thyroid carcinoma prognosis. This study explores short-term influences and factors affecting disease evolution.

Abstract e18083 Background: The value of sequencing cell-free DNA (cfDNA) from patients with papillary carcinoma of the thyroid (PTC) is controversial. Studies utilizing whole-exome sequencing (WES) ...